Aptus Pharma IPO is a Book Building IPO listing on BSE SME exchange, with an ipo size of ₹ 13.02 Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Interactive Financial Services is the merchant banker of Aptus Pharma IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 18th June 2025. Aptus Pharma IPO open date is 23rd September 2025 and close date is 25th September 2025. IPO Allotment Date is 26th September 2025 and Listing date is 30th September 2025.
Aptus Pharma IPO size is ₹ 13.02 Cr. with IPO price of ₹ 70.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Particulars | Amount |
---|---|
Capital Expenditure for Office Premises with furniture and Industrial Racks | 1 |
Working Capital | 8 |
General corporate purposes | [●] |
Interactive Financial Services Limited is the book-running lead manager of the Aptus Pharma IPO. Bigshare Services Private Limited is the Registrar and Market Maker is Market-Hub Stock Broking Private Limited for Aptus Pharma IPO.
Aptus Pharma IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Aptus Pharma IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on Marketing, and distribution of finished pharmaceutical formulations. The company is launching its SME IPO on the BSE SME exchange, using the Book Building Issue method. Aptus Pharma IPO size is ₹ 13.02 Cr. with fresh issue size of ₹ 13 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Aptus Pharma IPO is expected to be 26th September 2025, after the finalization of basis of allotment. Investors can check Aptus Pharma IPO allotment status on the registrars website, Bigshare Services Private Limited . Aptus Pharma IPO refund dates are 29th September 2025.
Aptus Pharma IPO is expected to be listed on 30th September 2025.
The upper price band for the Aptus Pharma IPO is set at ₹ 70.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Aptus Pharma IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Aptus Pharma IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 25th September 2025. After submission, funds are blocked until the basis of allotment of Aptus Pharma IPO is finalised.
The merchant banker for Aptus Pharma IPO is Interactive Financial Services Limited . Interactive Financial Services Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Aptus Pharma IPO RHP for further details.
The registrar for Aptus Pharma IPO is Bigshare Services Private Limited . Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Aptus Pharma IPO through their official website or helpline.
Aptus Pharma IPO was subscribed 22.27 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Aptus Pharma IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Aptus Pharma Financial Review Page
Merchant Banker(s) of Aptus Pharma IPO: Interactive Financial Services Limited
Aptus Pharma IPO subscription was 22.27 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Aptus Pharma IPO listed at a listing price of 80.80 against the offer price of 70.00.
The current market price of Aptus Pharma is 88.32.
Why Us?